Gold Nanorods with Spatial Separation of CeO2 Deposition for Plasmonic-Enhanced Antioxidant Stress and Photothermal Therapy of Alzheimer’s Disease

• DOI: 10.1021/acsami.1c17861
• Publication Date: 2022-01-13T16:23:05Z
• Authors: Kezhen Ge; Yingfeng Mu; Miaoyan Liu; Zetai Bai; Zhao Liu; Deqin Geng; Fenglei Gao
• Keywords: Amyloid beta-Peptides; Nanotubes; Photothermal Therapy; Biocompatible Materials; Cerium; 02 engineering and technology; 01 natural sciences; Antioxidants; 0104 chemical sciences; Alzheimer Disease; Blood-Brain Barrier; 0103 physical sciences; Materials Testing; Humans; Gold; 0210 nano-technology

Activities of catalase (CAT) and superoxide dismutase (SOD) of ceria nanoparticles (CeO2 NPs) provide the possibility for their application in nervous system oxidative stress diseases including Alzheimer's disease (AD). The addition of hot electrons produced by a plasma photothermal effect can expand the photocatalytic activity of CeO2 to the near-infrared region (NIR), significantly improving its redox performance. Therefore, we coated both ends of gold nanorods (Au NRs) with CeO2 NPs, and photocatalysis and photothermal therapy in the NIR are introduced into the treatment of AD. Meanwhile, the spatially separate structure enhances the catalytic performance and photothermal conversion efficiency. In addition, the photothermal effect significantly improves the permeability of the blood-brain barrier (BBB) and overcomes the shortcomings of traditional anti-AD drugs. To further improve the therapeutic efficiency, Aβ-targeted inhibitory peptides were modified on the middle surface of gold nanorods to synthesize KLVFF@Au-CeO2 (K-CAC) nanocomposites. We have verified their biocompatibility and therapeutic effectiveness at multiple levels in vitro and in vivo, which have a profound impact on the research and clinical transformation of nanotechnology in AD therapy.